Results 141 to 150 of about 388,090 (360)

Gut microbiota and tuberculosis

open access: yesiMeta, EarlyView.
This review explores the intricate relationship between gut microbiota (GM) and tuberculosis (TB). The figure illustrates the bidirectional effects between GM dynamics and TB progression, as well as the interactions between the GM and antituberculosis drugs.
Yanhua Liu   +39 more
wiley   +1 more source

Detection of HIV‐1 Antibodies in Saliva of Persons Living With HIV Using Blood‐Based First Response HIV 1‐2.O Card Test

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
The sensitivity of detecting HIV‐1 antibodies in saliva samples collected with the Self‐Lollisponge device was 72.9% (86/118). Detection of HIV‐1 antibodies in saliva depended on the presence of opportunistic infections, stomatorrhagia, and abnormal viral load (> 75 copies/mL) The Self‐Lollisponge device was found to be user‐friendly, acquiescent to ...
Enoch Aninagyei   +7 more
wiley   +1 more source

Efanesoctocog Alfa Population Pharmacokinetics and Repeated Time‐To‐Event Analysis of Bleeds in Adults, Adolescents, and Children with Severe Hemophilia A

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Efanesoctocog alfa is a first‐in‐class high‐sustained factor VIII (HSF) replacement therapy for treatment of hemophilia A. This article presents population pharmacokinetics (PopPK) of efanesoctocog alfa and repeated time‐to‐event (RTTE) analysis of bleeding episodes in adults/adolescents (≥12 years of age) and children (<12 years).
Nancy Wong   +7 more
wiley   +1 more source

Aspects of HIV infection and treatment [PDF]

open access: yes, 2010
Anti-retroviral therapy in the treatment of HIV (human immunodeficiency virus) aims to lower the viral load and improve immune function. Numerous interventions in the management of HIV seropositive patients are aimed to maximise individual patient ...
Mallia, Daniela
core  

Clinical Evaluation of Drug–Drug Interactions Between Bictegravir and Strong Inhibitors/Inducers of the CYP3A4, UGT1A1, or P‐gp Pathways

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract In addition to antiretroviral therapy (ART), people with HIV often take medications to treat comorbidities. It is therefore important to assess these medications for potential drug‐drug interactions, which may affect the safety and efficacy of ART. Three phase I studies were conducted in adult participants without HIV. The pharmacokinetics (PK)
Priyanka Arora   +4 more
wiley   +1 more source

HIV-1 Superinfection in an HIV-2-Infected Woman with Subsequent Control of HIV-1 Plasma Viremia [PDF]

open access: yes, 2017
A human immunodeficiency virus type 2 (HIV-2)-infected woman experienced asymptomatic superinfection with HIV-1 subtype AG. She did not have cross-neutralizing autologous HIV-1 antibodies before and shortly after HIV-1 superinfection.
Böni, Jürg   +6 more
core  

Shining stars in the sky on the gastric mucosa

open access: yesJournal of General and Family Medicine, EarlyView.
We report a rare case of an elderly Japanese man diagnosed with sporadic gastric Burkitt lymphoma. Esophagogastroduodenoscopy showed nodular and ulcerated lesions in the lesser curvature of the stomach. Pathological analysis of showed that the gastric lesions are characterized by a diffuse and dense accumulation of dark atypical lymphocytes (night) and
Kosuke Minaga   +3 more
wiley   +1 more source

The role of artificial intelligence in pharmacy: Revolutionizing drug development and beyond

open access: yesJournal of Intelligent Medicine, EarlyView.
This comprehensive review explores the integration of artificial intelligence (AI) in the field of pharmacy, covering advancements in drug discovery, personalized medicine, medication management, and patient care. It synthesizes current research, methodologies, and future prospects, offering insights into how AI technologies are reshaping ...
Usman Shettima Usman   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy